Are you Dr. Catchatourian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 34 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1900 W Polk St
Suite 751
Chicago, IL 60612Phone+1 312-854-7257Fax+1 312-864-9002- Is this information wrong?
Summary
- Dr. Rosalind Catchatourian, MD is an oncologist in Chicago, Illinois. She is currently licensed to practice medicine in Illinois and California.
Education & Training
- University of Illinois College of Medicine at ChicagoFellowship, Hematology and Medical Oncology, 1972 - 1975
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1970 - 1972
- West Suburban Medical CenterInternship, Transitional Year, 1969 - 1969
- National Taiwan University College of MedicineClass of 1967
Certifications & Licensure
- CA State Medical License 1975 - Present
- IL State Medical License 1972 - 2020
Clinical Trials
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2008 Mar 12
- S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases Start of enrollment: 2008 Dec 01
- A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
Publications & Presentations
PubMed
- 34 citationsA randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia.John Mascarenhas, Heidi E Kosiorek, Josef T Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub, Claire N Harrison, Mary Frances McMullin, Alessandro M V...> ;Blood. 2022 May 12
- 108 citationsPegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyureaAbdulraheem Yacoub, John Mascarenhas, Heidi E. Kosiorek, Josef T. Prchal, Dmitriy Berenzon, Maria R. Baer, Ellen K. Ritchie, Richard T. Silver, Craig M. Kessler, Ellio...> ;Blood. 2019 Oct 31
- 18 citationsA prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis.John Mascarenhas, Heidi E. Kosiorek, J. T. Prchal, Abdulraheem Yacoub, Dmitriy Berenzon, Maria R. Baer, Ellen K. Ritchie, Richard T. Silver, Craig M. Kessler, Elliot F...> ;Leukemia. 2019 Jul 30
- Join now to see all
Professional Memberships
- Member